By Nascent Biotech Posted January 14, 2015 In HAH_2015_CFP_Leaflet-22015-01-142015-01-14http://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.pngNascent Biotechhttp://www.nascentbiotech.com/wp-content/uploads/2015/06/nascent-logo-horiz-300.png200px200px 0 HAH_2015_CFP_Leaflet-2 Recent PostsNascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394Nascent Begins Enrollment of Final Patient Cohort to Complete Phase One Clinical ResearchNascent Biotech Completes Fourth Cohort in Phase 1 Human Trial for Primary and Metastatic Brain CancerNascent Biotech Receives Notice of Allowance from USPTO for Issuance of Additional Patent
